Endo Pharmaceuticals Solutions Inc. Business Finance Contracts & Agreements

21 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture to 6.25% Convertible Senior Notes Due 2009 – Endo Pharmaceuticals Solutions Inc., Endo Pharmaceuticals Holdings Inc., and The Bank of New York...
Indenture Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
2009
Pledge and Security Agreement between Equityholders and U.S. Bank National Association as Trustee (August 26, 2008)
Pledge Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
NY
2008
Indenture Agreement between Ledgemont Royalty Sub LLC and U.S. Bank National Association (August 26, 2008)
Indenture Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
DE
2008
Note Purchase Agreement among Ledgemont Royalty Sub LLC, Indevus Pharmaceuticals, Inc., and Purchaser for $105,000,000 Secured Notes
Note Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
DE
2008
Purchase and Sale Agreement between Indevus Pharmaceuticals, Inc. and Ledgemont Royalty Sub LLC dated August 26, 2008
Purchase Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
DE
2008
Indevus Pharmaceuticals Deferred Stock Unit Grant to Non-Employee Directors
Equity Distribution Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
2008
Asset Purchase Agreement between Valera Pharmaceuticals, Inc. and Anthra Pharmaceuticals, Inc. (Valrubicin Business)
Purchase Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
PA
2007
Indevus Pharmaceuticals Deferred Stock Unit Grant Agreement for Non-Employee Directors (April 30, 2007)
Equity Distribution Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
2007
Indenture Agreement for 6.25% Convertible Senior Notes due 2009 between Indevus Pharmaceuticals, Inc. and The Bank of New York Trust Company, N.A.
Indenture Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
NY
2007
Octreotide Contingent Stock Rights Agreement between Indevus Pharmaceuticals, Inc. and American Stock Transfer & Trust Company (April 17, 2007)
Warrant Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
DE
2007
Stent Contingent Stock Rights Agreement between Indevus Pharmaceuticals, Inc. and American Stock Transfer & Trust Company (April 17, 2007)
Warrant Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
DE
2007
Supprelin Contingent Stock Rights Agreement between Indevus Pharmaceuticals, Inc. and American Stock Transfer & Trust Company
Warrant Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
DE
2007
Side Letter Agreement Regarding Registration Rights for Indevus Pharmaceuticals, Inc. and Valera Pharmaceuticals, Inc. Merger
Registration Rights Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
2007
Amendment and Agreement between Indevus Pharmaceuticals, Inc. and Madaus GmbH (November 3, 2006)
Modification Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
2006
Underwriting Agreement between Indevus Pharmaceuticals, Inc. and Managing Underwriters for 7,000,000 Shares of Common Stock
Underwriting Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
NY
2006
Asset Purchase Agreement between Savient Pharmaceuticals, Inc. and Indevus Pharmaceuticals, Inc. dated December 12, 2005
Purchase Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
DE
2005
Amendment and Consent Agreement among Indevus Pharmaceuticals, Odyssey Pharmaceuticals, and Saturn Pharmaceuticals (May 14, 2005)
Modification Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
2005
Assignment and Termination Agreement between Manhattan Pharmaceuticals, Inc. and Indevus Pharmaceuticals, Inc. dated August 22, 2003
Assignment Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
NY
2003
Resale Registration Rights Agreement between Indevus Pharmaceuticals, Inc., Lehman Brothers Inc., and Wachovia Capital Markets, LLC (July 16, 2003)
Registration Rights Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
NY
2003
Indenture Agreement for 6.25% Convertible Senior Notes due 2008 between Indevus Pharmaceuticals, Inc. and The Bank of New York
Indenture Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
NY
2003
Stock Purchase Agreement between Interneuron Pharmaceuticals, Inc. and Investor (Form Agreement)
Stock Agreements
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
MA
2002